Research & Development



  阿嬌舉著盤子晃了一下問道︰“都是?”   太宰睡著了,他的帽子掉在了地上,被流動的空氣吹得滾來滾去,滿頭的白發也肆意的舞動著,只是臉上帶著溫暖的笑意。亚洲成av人片在线观看   “吃了一個多月的豬食……”李敢悲憤的對雲瑯道。色偷拍亚洲偷自拍视频   阿嬌見大長秋不言語,就什麼都明白了,嘆了口氣道︰“阿彘這些年都干了些什麼?就一點都不憐惜祖宗留下的江山社稷嗎?”   廢先王之道,焚百家之言,以愚黔首;隳名城,殺豪杰;收天下之兵,聚之成陽,銷鋒鏑,鑄以為金人十二,以弱天下之民。国产亚洲精品在线视频   太宰嘆息一聲道︰“你把成蔭君的尸體推下去做什麼,人家是皇族,我還能走的動路。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo